An Escalating Dose Indomethacin for the Treatment of Persistent Patent Ductus Arteriosus (PDA) In Preterm Infants

NCT00750581 · clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
TERMINATED
Status
9
Enrollment
OTHER
Sponsor class

Stopped Study medication was no longer available for study

Conditions

Interventions

Sponsor

University of Calgary